IRIS Accounts Production v24.1.4.33 13424946 Board of Directors 1.6.23 31.5.24 31.5.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh134249462023-05-31134249462024-05-31134249462023-06-012024-05-31134249462022-05-31134249462022-06-012023-05-31134249462023-05-3113424946ns15:EnglandWales2023-06-012024-05-3113424946ns14:PoundSterling2023-06-012024-05-3113424946ns10:Director12023-06-012024-05-3113424946ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3113424946ns10:Micro-entities2023-06-012024-05-3113424946ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3113424946ns10:FullAccounts2023-06-012024-05-3113424946ns5:CurrentFinancialInstruments2024-05-3113424946ns5:CurrentFinancialInstruments2023-05-3113424946ns5:Non-currentFinancialInstruments2024-05-3113424946ns5:Non-currentFinancialInstruments2023-05-3113424946ns10:RegisteredOffice2023-06-012024-05-31134249461ns10:Director12023-05-31134249461ns10:Director12022-05-31134249461ns10:Director12023-06-012024-05-31134249461ns10:Director12022-06-012023-05-31134249461ns10:Director12024-05-31134249461ns10:Director12023-05-31
REGISTERED NUMBER: 13424946 (England and Wales)






















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2024

FOR

CARNELL MEDICAL SERVICES LTD

CARNELL MEDICAL SERVICES LTD (REGISTERED NUMBER: 13424946)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024










Page

Balance sheet 1


CARNELL MEDICAL SERVICES LTD (REGISTERED NUMBER: 13424946)

BALANCE SHEET
31 MAY 2024

2024 2023
£    £   
FIXED ASSETS 46,888 59,660

CURRENT ASSETS 171,756 126,083

CREDITORS
Amounts falling due within one year (78,988 ) (34,225 )
NET CURRENT ASSETS 92,768 91,858
TOTAL ASSETS LESS CURRENT
LIABILITIES

139,656

151,518

CREDITORS
Amounts falling due after more than one
year

(20,956

)

(36,519

)
NET ASSETS 118,700 114,999

CAPITAL AND RESERVES 118,700 114,999

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Carnell Medical Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 13424946

Registered office: Elfed House
Oak Tree Court
Cardiff Gate Business Park
Cardiff
CF23 8RS

The presentation currency of the financial statements is Pound Sterling (£).

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

CARNELL MEDICAL SERVICES LTD (REGISTERED NUMBER: 13424946)

BALANCE SHEET - continued
31 MAY 2024

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 May 2024 and 31 May 2023:

2024 2023
£    £   
Dr J C Carnell
Balance outstanding at start of year 1,290 776
Amounts advanced 312 1,826
Amounts repaid (1,290 ) (1,312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 312 1,290



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 14 November 2024 and were signed on its behalf by:





Dr J C Carnell - Director